Literature DB >> 10675435

Pharmacologic paralysis and withdrawal of mechanical ventilation at the end of life.

R D Truog1, J P Burns, C Mitchell, J Johnson, W Robinson.   

Abstract

Entities:  

Keywords:  Death and Euthanasia

Mesh:

Substances:

Year:  2000        PMID: 10675435     DOI: 10.1056/NEJM200002173420712

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Ethical debate: The distinction between withdrawing life sustaining treatment under the influence of paralysing agents and euthanasia. Are we treading a fine line?

Authors:  K Street; J Henderson
Journal:  BMJ       Date:  2001-08-18

2.  An ICU ethics consultation: a second look.

Authors:  Stephanie M Vertrees; James L Bernat
Journal:  Neurocrit Care       Date:  2009-03-27       Impact factor: 3.210

3.  Neuromuscular blockers--a means of palliation?

Authors:  L Hawryluck
Journal:  J Med Ethics       Date:  2002-06       Impact factor: 2.903

4.  The agony of agonal respiration: is the last gasp necessary?

Authors:  R M Perkin; D B Resnik
Journal:  J Med Ethics       Date:  2002-06       Impact factor: 2.903

5.  End-of-life decisions in intensive care units: attitudes of physicians in an Italian urban setting.

Authors:  Alberto Giannini; Adriano Pessina; Enrico Maria Tacchi
Journal:  Intensive Care Med       Date:  2003-09-11       Impact factor: 17.440

Review 6.  Ethical reflections on end-of-life signs and symptoms in the intensive care setting: a place for neuromuscular blockers?

Authors:  Cédric Daubin; Lise Haddad; Dominique Folscheid; Alexandre Boyer; Ludivine Chalumeau-Lemoine; Olivier Guisset; Philippe Hubert; Jérôme Pillot; René Robert; Didier Dreyfuss
Journal:  Ann Intensive Care       Date:  2014-07-08       Impact factor: 6.925

7.  Compassionate extubation for a peaceful death in the setting of a community hospital: a case-series study.

Authors:  Victor C Kok
Journal:  Clin Interv Aging       Date:  2015-04-04       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.